Breaks Categories: News

ThursdayFeb 10, 2022 12:21 pm

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Notice of Allowance by USPTO for Smart Medical Inhaler System

RYAH Group (CSE: RYAH) today announced that the U.S. Patent and Trademark Office (the “USPTO”) has issued a Notice of Allowance for U.S. patent application number 15/924,172, filed in respect of the company's IoT-powered, Smart Medical Inhaler system by its wholly owned subsidiary, Potbotics Inc. The hybrid conduction and convection RYAH Smart Medical Inhaler was recently granted Medical Device Certification under ISO 13485:2016/MDSAP and EN ISO 13485:2016 standards for both its hardware and software. “Receiving this Notice of Allowance by the USPTO on our Smart Medical Inhaler is the result of dedication and great effort by all of our product…

Continue Reading

WednesdayFeb 09, 2022 12:43 pm

CannabisNewsBreaks – VPR Brands LP (VPRB) Unveils New Dissim Sport and Dissim Slim Lighters to ‘Best Focus Group’ for Pre-Launch Reaction

VPR Brands (OTC: VPRB) recently debuted its new Dissim Sport and Dissim Slim Line Lighters at the 2022 TPE Tobacco Plus Expo, held in Las Vegas from Jan. 26-28, 2022, and the Champs Trade Show on Feb. 2-5, 2022, at the Las Vegas Convention Center. According to the update, the Slim and Sport line within the Dissim family of lighters will launch with an opening price point between $8-$28 MSRP respectively and are expected to bring a new audience and open new distribution channels. “I personally attended TPE this year so I could interact with the distributors firsthand and gauge…

Continue Reading

TuesdayFeb 08, 2022 2:59 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Reaches ‘Major Milestone,’ Closes on Acquisition

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, through its wholly owned subsidiary RWB Michigan LLC, has closed on the acquisition of PharmaCo Inc. The acquisition, which was originally announced in 2020, brings an extensive list of assets to RWBYF, including 21 medical and adult-use cannabis licenses, eight fully operating dispensaries with five dually licensed, two operational indoor cultivation facilities totaling more than 30,000 square feet, one municipally licensed 10-acre outdoor cultivation facility ready for the 2022 season, two ready-to-open dispensaries, and22 owned properties for potential additional cultivation and dispensary locations.…

Continue Reading

TuesdayFeb 08, 2022 10:43 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces New Chief Strategy Officer

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has named Vessel founder and CEO James Chose as its new chief strategy officer. Choe brings impressive experience to his new role, with exposure to almost every major industry and a consulting business that has worked with more than 100 brands to launch more than 400 products. In particular, his time spent consulting for leading brands, cannabis producers and Fortune 500 companies has prepared Choe to serve as chief strategy office, where he will work on developing three core pillars: people, design, and community.…

Continue Reading

WednesdayFeb 02, 2022 2:20 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Significant Findings from Sildenafil Animal Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has reported positive findings in its recent animal study. The study was designed to evaluate LEXX’s proprietary DehydraTECH(TM) processing of the phosphodiesterase inhibitor ("PDE5 inhibitor") sildenafil for potential use in the management of erectile dysfunction. According to the company, the DehydraTECHsildenafil delivered 74% more drug at four minutes than the concentration-matched, generic control formulation with faster and higher overall delivery of sildenafil into the bloodstream evidenced over the course of the study. The most recognizable sildenafil product available currently is Viagra(R), but some users find it slow to act. Lexaria hopes…

Continue Reading

WednesdayFeb 02, 2022 12:37 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Seeks Approval to Study Patent-Pending Cannabinoid-Based Product to Treat COVID-19

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is hoping to begin research on its patent-pending, cannabinoid-based product. The company is requesting approval from INVIMA, the Colombian FDA, noting that recent studies indicate the potential for cannabinoids to display viral inhibition. FLGC’s research division, Flora Pharma, has filed a USPTO provisional patent application regarding the company’s cannabinoid-based formula, and the company is hoping to take the product through clinical trials under an emergency use authorization (“EUA”) from INVIMA.According to the company, the intent of the study is to identify safe and efficacious…

Continue Reading

FridayJan 28, 2022 11:12 am

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Announces Closing of Embark Acquisition

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an innovative health and wellness beverages and products company, has closed on its acquisition of Embark Health Inc., solventless cannabis extraction and delivery technology provider. According to the company, the acquisition will be a significant driver of growth for BevCanna, accelerating its already strong upward trajectory. Embark owns a unique range of brands across all three cannabis 2.0 categories, meaning that BevCanna will now be able to sell differentiated and complementary adult-use and wellness products. In addition, Embark brings a British-Columbia-based, state-of-the-art production facility with $17 million  in tangible and intangible assets to…

Continue Reading

ThursdayJan 27, 2022 12:33 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Issues Annual Letter from CEO, Stakeholder Update

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today provided an annual letter from CEO Chris Bunka and a thorough strategic update to all stakeholders. In the update, Bunka described Lexaria’s key area of focus to improve the company’s understanding of the capabilities of its ground-breaking DehydraTECH(TM) drug-delivery technology to enhance its abilities to commercialize and profit from this technology platform. “DehydraTECH is not an EVOLUTION of existing technology – it is a REVOLUTIONARY new drug delivery platform,” Bunka explains in the letter. “Expecting entire industries to change overnight to adopt a revolutionary new process is…

Continue Reading

ThursdayJan 27, 2022 11:09 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Appoints Award-Winning Expert as SVP of Global Operations

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its appointment of operations and personnel development expert, Joël Reyes, as senior vice president of global operations. Reyes brings extensive experience in operations management and optimization, leadership and C-suite consultation and development, business development, and strategic consultative sales, both within startups and large corporations. “2022 is the year for Flora to rapidly grow sales and revenue, and being surgical in our operational execution at every touchpoint will be critical to achieving our goals,” said Luis Merchan, president and CEO of Flora Growth Corp.…

Continue Reading

ThursdayJan 27, 2022 10:31 am

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces MOU with Bazelet Pharma Ltd., Closing of Initial Tranche of Private Placement

RYAH Group (CSE: RYAH) today announced its entry into a memorandum of understanding (“MOU”) with Bazelet Pharma Ltd. and affiliates (together, “Bazelet”), the largest medical cannabis processing company in Israel, serving thousands of patients. According to the update, the collaboration is aimed at servicing Bazelet's patients using RYAH Smart Inhalers and data analytics, once certified as a medical device in Israel, with the goal of providing safe and accurate patient inhalation therapies in plant medicine. “Bazelet brings extraordinary depth and expertise within a well-established and fast-growing medical cannabis market. We're excited to be collaborating with Bazelet in bringing our smart…

Continue Reading